Anti-influenza virus drugs "Abigan ® Tablets
200mg" Notice of manufacturing and marketing approval in Japan of
Toyama Chemical Co., Ltd. of the Fujifilm Group (Head Office: Shinjuku-ku,Tokyo, President: Sugata
Ekitsukasa, below, Toyama Chemical), this time, tablet type of new
anti-influenza virus drugs "Abigan ® Tablets 200mg" (generic name :
Fabipirabiru, Research Code: T-705, I'll let you know since we acquired the
manufacturing and marketing approval of the following "Abigan").
Influenza viruses replicate genes in infected cells, to expand the infection to
other cells by the proliferation and release. Currently, neuraminidase
inhibitors are used to treat, whose is the release inhibiting to the prevent
the spread of infection, "Abigan" is, of preventing proliferation by
inhibiting gene replication in cells of the virus it is a drug with a new
mechanism (RNA polymerase inhibitor). From these characteristics of the drug,
avian influenza virus A (H5N1) and A (H7N9) antiviral effects are expected for
such, in the experimental animal level already effect is confirmed.
"Abigan" is based on the current situation surrounding the recent
influenza, new or re-emerging influenza virus infection occurs, and in case other
anti-influenza drugs such as neuraminidase inhibitors is invalid or effect
insufficient, new mechanism that it should be in usable condition to
"Abigan" with it is determined that there is a meaning, it became
approved for the first time in the world in the country.
"Abigan" is new or re-emerging influenza virus infection occurs, this
drug when it determines that when used for countermeasures against the
influenza virus countries are drugs administered to the patient will be
considered. Therefore, it is not intended to immediately sell for squid, do the
production and supply, etc. In response to the request from the Minister of
Health, Labour and Welfare.
Toyama Chemical, We take the expectations of society for "Abigan"
very seriously, and in case there was a production request from the Minister of
Health, Labour and Welfare, so that it can respond promptly while sufficiently
attention to distribution management and safety measures, stable supply system
I will continue to build.
Toyama Chemical Fujifilm Group aims to "contribute to the development of
the world's health care through new drug development" that as research and
development-oriented company.
<Product Overview "Abigan">
Brand Name Abigan ® Tablets 200mg
Generic name Fabipirabiru
Efficacy new or re-emerging influenza virus infection (However, other
anti-influenza virus drugs limited to those of the invalid or insufficient
effect.)
DOSAGE AND ADMINISTRATION usually, the first day as Fabipirabiru in adults is 2
times once 1600mg 1 day from the second day fifth day administered orally once
600mg 2 times a day. The total administration period to five days.
Manufacturing and marketing approval date March 24, 2014
